Abstract
Purpose
Primary intraocular lymphoma (PIOL) is a rare malignancy with an aggressive clinical course. It is usually considered as a subset of primary central nervous system lymphoma. Differential diagnosis should include infectious and non-infectious aetiologies, particularly the common masqueraders sarcoidosis, tuberculosis, viral retinitis and syphilis.
Patient
The article presents a case of bilateral vitreoretinal lymphoma manifesting as uveitis and vitritis resistant to corticosteroid therapy. The final diagnosis was based on a retinal biopsy.
Results
The patient was successfully treated with systemic and local therapy. Long-term complete remission (CR) was reached. The relapse of diffuse large B-cell lymphoma was revealed in the frontal left lobe after 48 months of CR duration.
Conclusion
The diagnosis of PIOL is always very difficult. Cooperation of pathologists, ophthalmologists and hematologists is required for a quick and accurate diagnosis. Local and systemic treatment is needed to achieve CR, but the relapse rate remains very high.
References
Faia LJ, Chan CC (2009) Primary intraocular lymphoma. Arch Pathol Lab Med 133(8):1228–1232
Jusufbegovic D, Kim V, Char DH (2015) Primary uveal lymphoma with epibulbar extension masquerading as an intraocular inflammation. Can J Ophthalmol 50(1):e24–e26. doi:10.1016/j.jcjo.2014.11.018
Coupland SE, Bechrakis NE, Anastassiou G, Foerster AM, Heiligenhaus A, Pleyer U, Hummel M, Stein H (2003) Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with masquerade syndrome. Graefes Arch Clin Exp Ophthalmol 241(10):860–870
Sagoo MS, Mehta H, Swampillai AJ, Cohen VM, Amin SZ, Plowman PN, Lightman S (2014) Primary intraocular lymphoma. Surv Ophthalmol 59(5):503–516. doi:10.1016/j.survophthal.2013.12.001 Epub 2013 Dec 31
Itty S, Olson JH, O’Connell DJ, Pulido JS (2009) Treatment of primary intraocular lymphoma (PIOL) has involved systemic, intravitreal or intrathecal chemotherapy and/or radiotherapy. Retina 29(3):415–416. doi:10.1097/IAE.0b013e318196b1f6
Itty S, Pulido JS. Rituximab for intraocular lymphoma (2009). Retina 29(2):129-32. doi: 10.1097/IAE.0b013e318192f574. Review
Chan CC, Rubenstein JL, Coupland SE, Davis JL, Harbour JW, Johnston PB, Cassoux N, Touitou V, Smith JR, Batchelor TT, Pulido JS (2011) Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist 16(11):1589–1599. doi:10.1634/theoncologist.2011-0210 Epub 2011 Nov 1
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest
Human and Animal Rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from the patient included in the study.
Rights and permissions
About this article
Cite this article
Kapelko-Slowik, K., Urbaniak-Kujda, D., Turno-Krecicka, A. et al. Primary Intraocular Diffuse Large B-cell Lymphoma: Diagnostic Difficulties in Deep Retinal Infiltrations with Vitritis. Indian J Hematol Blood Transfus 32 (Suppl 1), 143–147 (2016). https://doi.org/10.1007/s12288-015-0599-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-015-0599-x